ClinicalTrials.Veeva

Menu

Safety and Feasibility Study of the Chartis System

Pulmonx logo

Pulmonx

Status and phase

Completed
Phase 1

Conditions

Bronchoscopy

Treatments

Device: Chartis System

Study type

Interventional

Funder types

Industry

Identifiers

NCT00684684
PRT01028

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and feasibility of the Chartis System in measuring air flow and pressures in isolated lung compartments during bronchoscopy.

Enrollment

18 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled to undergo clinically indicated routine diagnostic bronchoscopy

Exclusion criteria

  • Hyperexcretive chronic bronchitis or excessive sputum secretion
  • Active pulmonary infection
  • FEV1 <20% predicted
  • FVC <50% predicted

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

18 participants in 1 patient group

1
Experimental group
Treatment:
Device: Chartis System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems